UBS Group AG - BIOTECH ACQUISITION COMPANY ownership

Back to all holdings Add to watchlist

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 59 filers reported holding BIOTECH ACQUISITION COMPANY in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q3 2022$19,0000.0%1,954
+1.3%
0.00%–
Q2 2022$19,000
+111.1%
1,929
+101.1%
0.00%–
Q1 2022$9,000
-65.4%
959
-63.2%
0.00%–
Q4 2021$26,000
+85.7%
2,608
+77.1%
0.00%–
Q3 2021$14,000–1,473–0.00%–
 Download
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q3 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BIOTECH ACQUISITION COMPANY shareholders